Imaging of macrophages in soft-tissue infection in rats: Relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics

Radiology

Volumn 234, Issue 3, 2005, Pages 765-775

  Lutz, Amelie M ^a   Weishaupt, Dominik ^a   Persohn, Elke ^b   Goepfert, Kerstin ^a   Froehlich, Johannes ^c   Sasse, Bernd ^a   Gottschalk, Jochen ^d   Marincek, Borut ^a   Kaim, Achim H ^e  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Froehlich Pharma Consulting   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e Hospital Im Schachen   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ABSCESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTRON MICROSCOPY; FEMALE; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; MACROPHAGE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; SIGNAL NOISE RATIO; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS;

ABSCESS; ANIMALS; CONTRAST MEDIA; FEMALE; IRON; MACROPHAGE ACTIVATION; MACROPHAGES; MAGNETIC RESONANCE IMAGING; OXIDES; PILOT PROJECTS; RATS; RATS, SPRAGUE-DAWLEY; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STATISTICS, NONPARAMETRIC;

EID: 13844276079     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2343031172     Document Type: Article

References (34)

1. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990; 175:494-498.
2. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175:489-493.
3. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A Jr. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997; 7:258-263.
4. Schulze E, Ferrucci JT Jr, Poss K, Lapointe L, Bogdanova A, Weissleder R. Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Invest Radiol 1995; 30:604-610.
5. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001; 103:415-422.
6. Hauger O, Delalande C, Trillaud H, et al. MR imaging of intrarenal macrophage infiltration in an experimental model of nephrotic syndrome. Magn Reson Med 1999; 41:156-162.
7. Hauger O, Delalande C, Deminiere C, et al. Nephrotoxic nephritis and obstructive nephropathy: evaluation with MR imaging enhanced with ultrasmall superparamagnetic iron oxide-preliminary findings in a rat model. Radiology 2000; 217:819-826.
8. Dousset V, Ballarino L, Delalande C, et al. Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. AJNR Am J Neuroradiol 1999; 20:223-227.
9. Dousset V, Delalande C, Ballarino L, et al. In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. Magn Reson Med 1999; 41:329-333.
10. Rausch M, Baumann D, Neubacher U, Rudin M. In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed 2002; 15:278-283.
11. Kanno S, Wu YJ, Lee PC, et al. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 2001; 104:934-938.
12. Stets C, Brandt S, Wallis F, Buchmann J, Gilbert FJ, Heywang-Kobrunner SH. Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO. J Magn Reson Imaging 2002; 16:60-68.
13. Sigal R, Vogl T, Casselman J, et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) - results of a phase-III multicenter clinical trial. Eur Radiol 2002; 12:1104-1113.
14. Daldrup-Link HE, Rummeny EJ, Ihssen B, Kienast J, Link TM. Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow. Eur Radiol 2002; 12:1557-1566.
15. Michel SC, Keller TM, Frohlich JM, et al. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 2002; 225:527-536.
16. Gellissen J, Axmann C, Prescher A, Bohndorf K, Lodemann KP. Extra- and intracellular accumulation of ultrasmall superparamagnetic iron oxides (USPIO) in experimentally induced abscesses of the peripheral soft tissues and their effects on magnetic resonance imaging. Magn Reson Imaging 1999; 17:557-567.
17. Kaim AH, Wischer T, O'Reilly T, et al. MR imaging with ultrasmall superparamagnetic iron oxide particles in experimental soft-tissue infections in rats. Radiology 2002; 225:808-814.
18. Kaim AH, Jundt G, Wischer T, et al. Functional-morphologic MR imaging with ultrasmall superparamagnetic particles of iron oxide in acute and chronic soft-tissue infection: study in rats. Radiology 2003; 227:169-174.
19. Chambon C, Clement O, Le Blanche A, Schouman-Claeys E, Frija G. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magn Reson Imaging 1993; 11:509-519.
20. Knollmann FD, Bock JC, Rautenberg K, Beier J, Ebert W, Felix R. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography: preliminary results of an animal study original investigation. Invest Radiol 1998; 33:637-643.
21. Kaim AH, Weber B, Kurrer MO, Gottschalk J, von Schulthess GK, Buck A. Autoradiographic quantification of 18F-FDG uptake in experimental soft-tissue abscesses in rats. Radiology 2002; 223:446-451.
22. Russel WMS, Burch RL. The principles of humane experimental technique. London, England: Methuen, 1959.
23. Jung CW, Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995; 13:661-674.
24. Reimer P, Tombach B. Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 1998; 8:1198-1204.
25. Bonnemain B. Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications - a review. J Drug Target 1998; 6:167-174.
26. Dousset V, Gomez C, Petry KG, Delalande C, Caille JM. Dose and scanning delay using USPIO for central nervous system macrophage imaging. Magma 1999; 8:185-189.
27. Culling C. Handbook of histopathologic and histochemical techniques. 3rd ed. London, England: Butterworths, 1974.
28. Bullock GR, Petrusz P. Techniques in immunohistochemistry. New York, NY: Academic Press, 1982.
29. Bourne JA. Handbook of immunoperoxidase staining methods. Santa Barbara, Calif: Immunohistochemistry Laboratory, Dako, 1984.
30. Johnston RB Jr. Current concepts: immunology - monocytes and macrophages. N Engl J Med 1988; 318:747-752.
31. Madri J. Inflammation and healing. In: Kissane JM, ed. Anderson's pathology. 9th ed. Vol 1. St Louis, Mo: Mosby, 1990; 67-110.
32. Richie A, ed. Inflammation. In: Boyd's textbook of pathology. 9th ed. Vol 1. Philadelphia, Pa: Lea & Febiger, 1990; 60-82.
33. Chan TW, Eley C, Liberti P, So A, Kressel HY. Magnetic resonance imaging of abscesses using lipid-coated iron oxide particles. Invest Radiol 1992; 27:443-449.
34. Josephson L, Lewis J, Jacobs P, Hahn PF, Stark DD. The effects of iron oxides on proton relaxivity. Magn Reson Imaging 1988; 6:647-653.